U.S., April 26 -- ClinicalTrials.gov registry received information related to the study (NCT06386315) titled 'Reduced Dose Radiotherapy for the Treatment of Indolent Non-Hodgkin Lymphoma' on April 23.
Brief Summary: This phase II trial compares the safety, side effects and effectiveness of reduced dose radiation therapy to standard of care dose radiation in treating patients with indolent non-Hodgkin lymphoma. Radiation therapy uses high energy x-rays, particles, or radioactive seeds to kill cancer cells and shrink tumors. Standard of care radiation treatment for indolent non-Hodgkin lymphoma is usually delivered in 12 treatments. Studies have shown indolent lymphoma to be sensitive to radiation treatment, however, larger doses have higher...